Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic gluconeogenesis is promoted by the PKA-mediated phosphorylation of the cAMP response element-binding protein, which in turn upregulates peroxisome proliferator-activated receptor-γ coactivator (PGC)-1.160 Together with the hepatocyte nuclear factor (HNF)-4, PGC-1 induces the transcription of phosphoenolpyruvate carboxykinase,161 which catalyzes the conversion of oxaloacetate into phosphoen”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [161]
In the citing paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [24]
In the citing paper
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
In the citing paper
“The metabolic shifts that occur in response to fasting highlight the non-equivalence of PGC-1α function in distinct tissues.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“The liver-specific insulin-receptor knockout (LIRKO) mouse is a unique model of hepato-specific insulin resistance in the liver, and is associated with impaired glucose tolerance and the failure of insulin to suppress hepatic glucose productio”
BackgroundSelf-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“This region of PGC-1 has previously been shown to mediate ligand-dependent interactions with the activation function-2 (AF-2) domains of several nuclear receptors, including oestrogen receptor-α (ERα), peroxisome proliferator-activated receptor-α (PPARα) and glucocorticoid recepto”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Glycogenolysis occurs more rapidly, beginning within 2–3 h after a meal in humans, but gluconeogenesis assumes a much greater importance with prolonged fastin”
BackgroundSelf-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“PGC-1 coactivates HNF-4α and the glucocorticoid receptor The mechanisms underlying the transcriptional activation of the gluconeogenic enzyme PEPCK have been extensively studie”
Background(1997) · Diabetes reviews · Cited by 671
Cited by
Items 301–400 of 1,002
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
Cornu, M., Oppliger, W., Albert, V., Robitaille, A. M., Trapani, F., Quagliata, L., Fuhrer, T., Sauer, U., Terracciano, L., & Hall, M. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412047111 · Cited by 152
HNF4α—role in drug metabolism and potential drug target?
Hwang-Verslues, W. W., & Sladek, F. M. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.08.010 · Cited by 146
“The energy/metabolic sensing kinase AMPK also phosphorylates both HNF4α and PGC1α thereby altering their activity [61,62].”
BackgroundInfluentialAharoni-Simon, M., Hahn-Obercyger, M., Pen, S., Madar, Z., & Tirosh, O. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.55 · Cited by 167
“Similar results were reported previously by others.(36,37) Our both in vivo and in vitro results suggest that PGC1a transcription is a sensor for decreased ATP levels.”
ResultMiura, S., Kai, Y., Kamei, Y., & Ezaki, O. (2008) · Endocrinology · doi:10.1210/en.2008-0466 · Cited by 151
Renal Gluconeogenesis: An Underestimated Role of the Kidney in Systemic Glucose Metabolism
Legouis, D., Faivre, A., Cippà, P. E., & de Seigneux, S. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa302 · Cited by 151
Wang, L., Liu, J., Saha, P. K., Huang, J., Chan, L., Spiegelman, B. M., & Moore, D. D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.010 · Cited by 154
Self-citationEstall, J. L., Kahn, M., Cooper, M. P., Fisher, F. M., Wu, M. K., Laznik, D., Qu, L., Cohen, D. E., Shulman, G. I., & Spiegelman, B. M. (2009) · Diabetes · doi:10.2337/db08-1571 · Cited by 148
“Using gain-offunction and complete-loss-of-function studies, these proteins were shown to be dominant regulators of oxidative metabolism, particularly mitochondrial biogenesis, skeletal muscle biology, brown fat thermogenesis, and the hepatic fasting response (4,5,7,11,14,16).”
InfluentialSelf-citationSanderson, L. M., Degenhardt, T., Koppen, A., Kalkhoven, E., Desvergne, B., Müller, M., & Kersten, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00370-09 · Cited by 144
“vious data (64), expression of Pgc1a went up significantly during fasting (Fig.”
BackgroundPrevention of Steatosis by Hepatic JNK1
Sabio, G., Cavanagh-Kyros, J., Ko, H. J., Jung, D. Y., Gray, S., Jun, J. Y., Barrett, T., Mora, A., Kim, J. K., & Davis, R. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.007 · Cited by 148
“Indeed, the liver of LKO mice ex- pressed increased amounts of PGC-1a (Figure S6), a coactivator of the gluconeogenic gene transcription factors HNF4a and FOXO1 (Puigserver et al., 2003; Yoon et al., 2001).”
BackgroundInfluentialGenetic determinants of hepatic steatosis in man
Hooper, A. J., Adams, L. A., & Burnett, J. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r008896 · Cited by 142
Dwyer, M. A., Joseph, J. D., Wade, H. E., Eaton, M. L., Kunder, R. S., Kazmin, D. A., Chang, C., & McDonnell, D. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0226 · Cited by 157
“While the transcriptional activity of ERRα is regulated by the relative expression and/or activity of cofactors such as PGC-1α and PGC-1β [19–20], other NRs, including PPARγ and HNF-4, can also be coactivated by PGC-1α, which makes it difficult to study the ERRα signaling axis in isolation using this cofactor as an ac…”
Gambino, R., Musso, G., & Cassader, M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3058 · Cited by 147
“In the liver, PGC-1a is expressed at low levels under normal fed conditions (223), but fasting produces a significant increase of PGC-1a expression, leading to stimulation of hepatic gluconeogenesis and FA oxidation (103, 353).”
Miura, S., Kai, Y., Ono, M., & Ezaki, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304312200 · Cited by 146
PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
Soyal, S. M., Krempler, F., Oberkofler, H., & Patsch, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0268-6 · Cited by 162
“Importantly, both hepatic Ppargc1a expression and gluconeogenesis are aberrantly induced in mouse models of insulin resistance and type 2 diabetes [62].”
BackgroundMolecular Mechanisms of Insulin Resistance in IRS-2-Deficient Hepatocytes
Valverde, A. M., Burks, D. J., Fabregat, I., Fisher, T. L., Carretero, J., White, M. F., & Benito, M. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2239 · Cited by 144
“Figure 8B demonstrates that PEPCK and G6Pase mRNA expression (induced by dexa- FIG.”
BackgroundInfluentialp38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis
Cao, W., Collins, Q. F., Becker, T. C., Robidoux, J., Lupo, E. G., Xiong, Y., Daniel, K. W., Floering, L., & Collins, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506223200 · Cited by 145
Role of Hepatocyte Nuclear Factor 4α (HNF4α) in Cell Proliferation and Cancer
Walesky, C., & Apte, U. (2015) · Gene Expression · doi:10.3727/105221615x14181438356292 · Cited by 137
Chen, M., Gavrilova, O., Zhao, W.-Q., Nguyen, A., Lorenzo, J., Shen, L., Nackers, L., Pack, S., Jou, W., & Weinstein, L. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24196 · Cited by 141
Premature aging in mice activates a systemic metabolic response involving autophagy induction
Mariño, G., Ugalde, A. P., Salvador-Montoliu, N., Varela, I., Quirós, P. M., Cadiñanos, J., van der Pluijm, I., Freije, J. M. P., & López-Otín, C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn120 · Cited by 143
“After these findings indicating the occurrence of marked alterations of glucose and lipid metabolism in Zmpste24 mice, we analyzed the status of the transcriptional co-activator Pgc-1a (peroxisome proliferator-activated receptor-gamma co-activator-1a), an essential regulator of hepatic gluconeogenesis (54) and fatty a…”
BackgroundKim, D.-K., Ryu, D., Koh, M., Lee, M.-W., Lim, D., Kim, M.-J., Kim, Y.-H., Cho, W.-J., Lee, C.-H., Park, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315168 · Cited by 134
“The orphan nuclear receptor HNF4 has been recognized to stimulate the gluconeogenic genes in a PGC-1 -dependent manner in response to fasting (5), whereas the NR4A pathway is PGC-1 -independent (55).”
BackgroundHepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice
Geisler, C. E., Hepler, C., Higgins, M. R., & Renquist, B. J. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0122-x · Cited by 135
“In fact, mice overexpressing PEPCK mRNA, have elevated hepatic glucose output both in vivo and in vitro [5, 33], while overexpression of G6Pase mRNA results in hyperglycemia, hyperinsulinemia, and an over 50 % reduction in liver glycogen [34, 35].”
BackgroundHepatic FXR: key regulator of whole-body energy metabolism
Teodoro, J. S., Rolo, A. P., & Palmeira, C. M. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.07.002 · Cited by 158
Yamamoto, T., Shimano, H., Nakagawa, Y., Ide, T., Yahagi, N., Matsuzaka, T., Nakakuki, M., Takahashi, A., Suzuki, H., Sone, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310333200 · Cited by 143
Connaughton, S., Chowdhury, F., Attia, R. R., Song, S., Zhang, Y., Elam, M. B., Cook, G. A., & Park, E. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.011 · Cited by 144
“Hepatic PGC-1α levels are elevated in streptozotocin-induced diabetes several models of type II diabetes [29].”
BackgroundSuppression of β Cell Energy Metabolism and Insulin Release by PGC-1α
Yoon, J. C., Xu, G., Deeney, J. T., Yang, S.-N., Rhee, J., Puigserver, P., Levens, A. R., Yang, R., Zhang, C.-Y., Lowell, B. B., et al. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00170-9 · Cited by 143
Self-citationCordero‐Herrera, I., Martín, M. Á., Bravo, L., Goya, L., & Ramos, S. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200500 · Cited by 143
“4), without phenol red (Invitrogen, Madrid, Spain), supplemented with 20 mM sodium lactate and 2 mM sodium pyruvate, as previously described [23,24].”
MethodMuller, Y. L., Bogardus, C., Pedersen, O., & Baier, L. (2003) · Diabetes · doi:10.2337/diabetes.52.3.895 · Cited by 142
Selenium transformation and selenium-rich foods
Chen, N., Zhao, C., & Zhang, T. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100875 · Cited by 148
Ichida, M., Nemoto, S., & Finkel, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210262200 · Cited by 138
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
Humphrey, E. L., Williams, J. H. H., Davie, M. W. J., & Marshall, M. J. (2006) · Bone · doi:10.1016/j.bone.2005.10.004 · Cited by 139
“(2003) who demonstrated that the dissociated ligand AL438 does not interact with the coactivator PGC-1, whereas prednisolone does [49].”
BackgroundGlucocorticoid Signaling Is Perturbed by the Atypical Orphan Receptor and Corepressor SHP
Borgius, L. J., Steffensen, K. R., Gustafsson, J.-Å., & Treuter, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205641200 · Cited by 134
Structural and Functional Consequences of Mitochondrial Biogenesis in Human Adipocytes in Vitro
Bogacka, I., Ukropcova, B., McNeil, M., Gimble, J. M., & Smith, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1024 · Cited by 138
The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis
Sun, Z., Jiang, Q., Li, J., & Guo, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00265-w · Cited by 148
Rog‐Zielinska, E. A., Craig, M.-A., Manning, J. R., Richardson, R. V., Gowans, G. J., Dunbar, D. R., Gharbi, K., Kenyon, C. J., Holmes, M. C., Hardie, D. G., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.181 · Cited by 143
Metabolic control through glucocorticoid hormones: An update
Rose, A. J., & Herzig, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.007 · Cited by 144
Zhang, L., Zhou, Y., Wu, W., Hou, L., Chen, H., Zuo, B., Xiong, Y., & Yang, J. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20132 · Cited by 142
“It is interesting to notice that PGC-1α has also been reported to induce expression of the dominant glucose transporter GLUT4 and glucose-6phosphatase in skeletal muscle, both of them are critical genes involved in gluconeogenesis [33, 34].”
BackgroundPGC-1α affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis
Kong, S., Cai, B., & Nie, Q. (2022) · Molecular Genetics and Genomics · doi:10.1007/s00438-022-01878-2 · Cited by 143
Kodama, S., Moore, R., Yamamoto, Y., & Negishi, M. (2007) · Biochemical Journal · doi:10.1042/bj20070481 · Cited by 136
PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
Estall, J. L., Ruas, J. L., Choi, C. S., Laznik, D., Badman, M., Maratos-Flier, E., Shulman, G. I., & Spiegelman, B. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912533106 · Cited by 134
“PGC-1 (cid:1) is a key regulator of the hepatic fasting response (5, 9, 36–40).”
BackgroundSelf-citationPirinen, E., Kuulasmaa, T., Pietilä, M., Heikkinen, S., Tusa, M., Itkonen, P., Boman, S., Skommer, J., Virkamäki, A., Hohtola, E., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02034-06 · Cited by 134
“Subsequent studies have demonstrated that PGC-1 regulates mitochondrial biogenesis (49), uncoupling (45, 56), fatty acid oxidation (61), OXPHOS (36), glucose transport in muscle (35), hepatic gluconeogenesis (64), and skeletal muscle fiber-type switching (44).”
BackgroundBuler, M., Aatsinki, S., Izzi, V., Uusimaa, J., & Hakkola, A. J. (2014) · The FASEB Journal · doi:10.1096/fj.13-245241 · Cited by 136
“PGC-1 , as well as PPAR and ERR , are induced in the liver by caloric restriction (5, 20, 28).”
BackgroundCurcumin inhibits hepatitis B virus via down‐regulation of the metabolic coactivator PGC‐1α
Rechtman, M. M., Har‐Noy, O., Bar-Yishay, I., Fishman, S., Adamovich, Y., Shaul, Y., Halpern, Z., & Shlomai, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.067 · Cited by 135
“We analyzed the mRNA level of the key gluconeogenesis gene G6Pase, a well-known target of PGC-1a coactivation [6,22].”
BackgroundMethodInfluentialFOXO family in regulating cancer and metabolism
Ma, J., Matkar, S. S., He, X., & Hua, X. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.018 · Cited by 138
Cui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., Liu, Q., Ma, W., Shen, Z., Shen, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci66062 · Cited by 142
Panserat, S., Plagnes‐Juan, E., & Kaushik, S. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00501-8 · Cited by 151
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 129
“The PGC-1a transcriptional coactivator is an important mediator of hepatic fasting metabolism; PGC-1a induces and C maintains expression of the gluconeogenic gene program during fasted states, responding to glucagon/cAMP through CRTC2 (Herzig et al., 2001; Koo et al., 2005; Rhee et al., 2003; Yoon et al., 2001).”
BackgroundSelf-citationZeng, Z., Yuan, Q., Yu, R., Zhang, J., Ma, H., & Chen, S. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900457 · Cited by 141
Nakatani, T., Tsuboyama-Kasaoka, N., Takahashi, M., Miura, S., & Ezaki, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110132200 · Cited by 132
Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids
Ferrebee, C. B., & Dawson, P. A. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.001 · Cited by 126
“This may be accomplished in part by FXR modulation of hepatic PGC1 α to repress expression of these gluconeogenic genes 29 .”
BackgroundTurpin-Nolan, S. M., Hoy, A. J., Brown, R. D., Rudaz, C. G., Honeyman, J. E., Matzaris, M., & Watt, M. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1895-5 · Cited by 137
RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression
Martínez, P., Gómez-López, G., García, F., Mercken, E., Mitchell, S., Flores, J. M., de Cabo, R., & Blasco, M. A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.030 · Cited by 126
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript augment the capacity of metabolic adaptation to activate gluconeogenesis and fatty acid oxidation (Yoon et al., 2001).”
BackgroundInfluentialSelva, D. M., & Hammond, G. L. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0025 · Cited by 123
“…the expression of other transcription factors that might influence SHBG expression, or coactivators, such as Trp-3, PGC-1a, Src-1, and Src-3 (Zhang & Lazar 2000) that influence the activities of transcription factors, including HNF-4a (Wang et al. 1998, Yoon et al. 2001, Iwahashi et al. 2002).”
BackgroundNovel Small-Molecule PGC-1α Transcriptional Regulator With Beneficial Effects on Diabetic db/db Mice
Zhang, L., Zhou, H., Fu, Y., Li, Y., Wu, F., Gu, M., Wu, L., Xia, C.-M., Dong, T., Li, J.-Y., et al. (2013) · Diabetes · doi:10.2337/db12-0703 · Cited by 132
“Liver gluconeogenesis is known to be highly regulated by PGC-1a (19).”
BackgroundSelective Glucocorticoid Receptor modulators
Bosscher, K. D. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.027 · Cited by 145
Hormonal regulation of gluconeogenic gene transcription in the liver
Yabaluri, N., & Bashyam, M. D. (2010) · Journal of Biosciences · doi:10.1007/s12038-010-0052-0 · Cited by 128
A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response
Iroz, A., Montagner, A., Benhamed, F., Levavasseur, F., Polizzi, A., Anthony, E., Régnier, M., Fouché, E., Lukowicz, C., Cauzac, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.065 · Cited by 128
“PGC-1b is known to activate genes responsible for fatty acid oxidation and hepatic gluconeogenesis during fasting (Vega et al., 2000; Yoon et al., 2001), and it was also reported to upregulate de novo lipogenic genes during glucose stimulation in a ChREBP-dependent manner (Chambers et al.”
BackgroundSpeckmann, B., Walter, P. L., Alili, L., Reinehr, R., Sies, H., Klotz, L.-O., & Steinbrenner, H. (2008) · Hepatology · doi:10.1002/hep.22526 · Cited by 127
PGC-1 coactivators in the cardiovascular system
Patten, I. S., & Arany, Z. P. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.09.007 · Cited by 134
Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
Zhang, Q., Xiao, X., Feng, K., Wang, T., Li, W., Yuan, T., Sun, X., Sun, Q., Xiang, H., & Wang, H. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2011/924851 · Cited by 124
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126
“PGC-1α PGC-1α is a transcriptional coactivator induced by glucagon and glucocorticoid signaling that facilitates gluconeogenesis (Yoon et al. 2001).”
BackgroundGu, L., Ding, X., Wang, Y., Gu, M., Zhang, J., Yan, S., Li, N., Song, Z., Yin, J., Lu, L., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31781 · Cited by 126
“They are crucial enzymes that convert pyruvate to glucose, and their gene expression levels are regulated by several transcription factors, such as Forkhead box O1 (FoxO1), cAMP response element binding protein (CREB), hepatocyte nuclear factor 4 (HNF4), glucocorticoid receptor, and peroxisome proliferator-activated r…”
BackgroundDiabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
Belosludtsev, K. N., Belosludtseva, N. V., & Dubinin, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186559 · Cited by 127
“Pancreatic Islets Heart Skeletal Muscles Brain Kidney Adipose Liver Biogenesis ↓ [11] ↑ [12] ↓↑ [13] ↓ [14] ↓ [15] ↓ [16] ↓ [17] ↓ [18] ↑ [19] Mitophagy ↓ [20] ↑ [21] ↓ [22] ↓ [23] ↓ [24] ↓ [25] ↑ [26] ↑ [27] ↓ [28] Fission/Fusion ↑/↓ [29] ↑/↓ [30] ↑ [31] ↓ [32] ↑/↓ [33] ↑/↓ [34] ↑ [35] ↓? ↑/↓ [36]”
Backgroundp38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes
Collins, Q. F., Xiong, Y., Lupo, E. G., Liu, H.-Y., & Cao, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602177200 · Cited by 122
Diani-Moore, S., Ram, P., Li, X., Mondal, P., Youn, D. Y., Sauve, A. A., & Rifkind, A. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.131573 · Cited by 123
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
Stulnig, T. M., & Waldh�usl, W. (2004) · Diabetologia · doi:10.1007/s00125-003-1284-4 · Cited by 140
“Glucocorticoids and CREB synergistically induce peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1), a key activator of hepatic gluconeogenesis [13, 14].”
BackgroundBesse-Patin, A., Jeromson, S., Levesque-Damphousse, P., Secco, B., Laplante, M., & Estall, J. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815150116 · Cited by 124
“Moreover, PGC1A knockdown decreased basal and glucagon-induced G6pc and Pepck mRNA, as previously described (5), as well as Hsl, another PGC1A target (20) not regulated by glucagon (SI Appendix, Fig.”
BackgroundThe role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome
Zhang, Z., Zhou, S., Jiang, X. M., Wang, Y., Li, F., Wang, Y., Zheng, Y., & Cai, L. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9305-9 · Cited by 127
“Previous studies demonstrated that FGF21 can induce PGC1α and its downstream gene phosphoenolpyruvate carboxykinase (PEPCK) [68], and an induction of PGC1α and PEPCK was observed in the livers of Nrf2-KO mice fed with HFD [36].”
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Vecchi, C., Montosi, G., Garuti, C., Corradini, E., Sabelli, M., Canali, S., & Pietrangelo, A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.016 · Cited by 123
Luo, P., Chang, H.-H., Zhou, Y., Zhang, S., Hwang, S. H., Morisseau, C. H. P., Wang, C., Inscho, E. W., Hammock, B. D., & Wang, M.-H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167544 · Cited by 128
“STZ as described previously (Yoon et al., 2001).”
Estrogen-related receptor α as a therapeutic target in cancer
Stein, R. A., & McDonnell, D. P. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01292 · Cited by 113
Mounier, C., & Posner, B. I. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-152 · Cited by 114
“In addition, the insulin-stimulated phosphorylation of Foxo1 disrupts its binding to the PGC-1a coactivator (Yoon et al. 2001), abolishes HNF-4a binding to the dAF1 site (Yamamoto et al.”
BackgroundSIRT1 metabolic actions: Integrating recent advances from mouse models
Boutant, M., & Cantó, C. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.10.006 · Cited by 121
“This, in turn, impinges on the likelihood/tendency of organisms to develop metabolic and age-related diseases, including insulin resistance, cancer and neurodegeneration.”
BackgroundAndrulionyt�, L., Zacharova, J., Chiasson, J. L., Laakso, M., & for the STOP-NIDDM Study Group (2004) · Diabetologia · doi:10.1007/s00125-004-1577-2 · Cited by 133
“Moreover, PGC1α regulates the determination of muscle fibre type [32], enhances glucose uptake by controlling insulinsensitive glucose transporter (GLUT-4) expression in muscle cells [33] and is implicated in hepatic gluconeogenesis by increasing gene transcription of phosphoenolpyruvate carboxykinase and glucose-6-ph…”
BackgroundOrgan-specific mediation of lifespan extension: More than a gut feeling?
Rera, M., Azizi, M. J., & Walker, D. W. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.05.003 · Cited by 106
Kurtz, C. L., Peck, B. C. E., Fannin, E. E., Beysen, C., Miao, J., Landstreet, S. R., Ding, S., Turaga, V., Lund, P. K., Turner, S., et al. (2014) · Diabetes · doi:10.2337/db13-1015 · Cited by 125
“FOXA2 is negatively regulated by insulin (33,34) and opposes insulin action (35) by promoting hepatic lipid catabolism and fatty acid oxidation (36).”
BackgroundPGC-1α over-expression promotes recovery from mitochondrial dysfunction and cell injury
Rasbach, K. A., & Schnellmann, R. G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.023 · Cited by 121
Retinoid Receptors and Their Coregulators
Wei, L.-N. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140301 · Cited by 115
PPARδ, but not PPARα, activates PGC-1α gene transcription in muscle
Hondares, E., Pineda-Torra, I., Iglesias, R., Staels, B., Villarroya, F., & Giralt, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.092 · Cited by 120
Tsunemi, T., & La Spada, A. R. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.004 · Cited by 117
Nicholas, L. M., Rattanatray, L., MacLaughlin, S. M., Ozanne, S. E., Kleemann, D. O., Walker, S. K., Morrison, J. L., Zhang, S., Muhlhäusler, B. S., Martin‐Gronert, M. S., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-227918 · Cited by 114
The metabolic modulator PGC-1α in cancer.
Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 169
Review on the health-promoting effect of adequate selenium status
Sun, Y., Wang, Z., Gong, P., Yao, W., Ba, Q., & Wang, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1136458 · Cited by 127
“This is primarily because high selenium intake increases the expression of peroxisome proliferator-activated receptor coactivator (PGC-1), a transcriptional coactivator involved in cellular energy metabolism, which may be one of the primary causes of hyperglycemia associated with high selenium intake (119).”
BackgroundMeta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes
Barroso, I., Luan, J., Sandhu, M. S., Franks, P. W., Crowley, V., Schafer, A. J., O’Rahilly, S., & Wareham, N. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0130-2 · Cited by 130
“PPARGC1A also plays a key role in the regulation of hepatic glucose output through the control of gluconeogenesis [4, 5], and modulates the expression of the insulinElectronic Supplementary Material Supplementary material is available for this article at http://dx.”
Backgroundvan der Veen, J. N., Lingrell, S., da Silva, R. P., Jacobs, R. L., & Vance, D. E. (2014) · Diabetes · doi:10.2337/db13-0993 · Cited by 114
“The protein levels of peroxisome proliferator–activated receptor g coactivator (Pgc)1a, a transcription factor that influences hepatic glucose production (21), were also unaffected by PEMT deficiency (Fig.”
Insulin Signaling in the Control of Glucose and Lipid Homeostasis
Saltiel, A. R. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_14 · Cited by 135
Glucocorticoids and Metabolic Control
Magomedova, L., & Cummins, C. L. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_1 · Cited by 127
“Under fasting conditions, the expression of Pgc1α is induced synergistically by glucagon and GCs (Yoon et al. 2001).”
BackgroundMolecular recognition by the KIX domain and its role in gene regulation
Thakur, J. K., Yadav, A., & Yadav, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1147 · Cited by 134
“CREB not only regulates hepatic gluconeogenesis during fasting and in diabetes (89,90), but is also found to be over-expressed in different types of cancers (88,91).”
BackgroundSeparation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase
Lustig, Y., Ruas, J. L., Estall, J. L., Lo, J. C., Devarakonda, S., Laznik, D., Choi, J. H., Ono, H., Olsen, J. V., & Spiegelman, B. M. (2011) · Genes & Development · doi:10.1101/gad.2054711 · Cited by 116
“This occurs through coactivation of hepatic ERRa, NRF1, NRF2, PPARa, HNF4a, and FOXO1 (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003; Koo et al. 2004; Handschin et al. 2005;Wu et al. 2009).”
BackgroundMethodSelf-citationRegulation of P450 genes by liver-enriched transcription factors and nuclear receptors
Akiyama, T. E., & Gonzalez, F. J. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00480-4 · Cited by 136
Obesity therapy: altering the energy intake-and-expenditure balance sheet
Crowley, V., Yeo, G. S. H., & O’Rahilly, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd770 · Cited by 130
Fu, Q., McKnight, R. A., Yu, X., Wang, L., Callaway, C. W., & Lane, R. H. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00175.2004 · Cited by 114
“PGC-1 is a transcriptional coactivator that mediates hepatic glucose production by controlling mRNA levels of key gluconeogenic enzymes, such as glucose-6phosphatase (G-6-Pase), phosphoenolpyruvate carboxykinase (PEPCK), and fructose-1,6-bisphosphatase (FBPase) (63).”
BackgroundFarnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
Massafra, V., & van Mil, S. W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.003 · Cited by 122
Down-Regulation of Hepatic HNF4α Gene Expression during Hyperinsulinemia via SREBPs
Xie, X., Liao, H., Dang, H., Pang, W., Guan, Y., Wang, X., Shyy, J. Y.-J., Zhu, Y., & Sladek, F. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2007-0531 · Cited by 111
Cassuto, H., Kochan, K., Chakravarty, K., Cohen, H., Blum, B., Olswang, Y., Hakimi, P., Xu, C., Massillon, D., Hanson, R. W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504119200 · Cited by 109
Liang, J., Liu, C., Qiao, A., Cui, Y., Zhang, H., Cui, A., Zhang, S., Yang, Y., Xiao, X., Chen, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.024 · Cited by 119
van Waveren, C., & Moraes, C. T. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-18 · Cited by 116
“PGC-1α is mainly expressed in tissues with high energy demand and high mitochondrial content, such as heart, brain, kidney and brown fat, and is induced by fasting and exposure to cold [21-25].”
Caseras, A., Metón, I., Vives, C., Egea, M., Fernández, F., & Baanante, I. V. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002701 · Cited by 114
“IP address: 54.191.40.80, on 03 May 2017 at 13:24:37, subject to the Cambridge Core terms of use, available at hepatic glucose output through stimulation of the expression of G6Pase and other gluconeogenic enzymes (Herzig et al. 2001; Yoon et al. 2001).”
BackgroundInfluentialChakkera, H. A., Kudva, Y. C., & Kaplan, B. E. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.546 · Cited by 114
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippe, J., & Jornayvaz, F. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 113
“[100] Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, et al.”
BackgroundMinireview: New Molecular Mediators of Glucocorticoid Receptor Activity in Metabolic Tissues
Patel, R., Williams-Dautovich, J., & Cummins, C. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1062 · Cited by 108
“), glucocorticoid receptor interacting protein 1, p160 transcriptional cofactor steroid receptor coactivator 1 (SRC-1), and the acetyltransferase p300/cAMP response element binding protein (CREB)-binding protein (CBP) are also involved in Pepck transactivation (20, 53–56).”
Metadata
- Authors
- Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6852
- Pages
- 131-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1523158326
- Cited by
- 1,821
- References
- 33
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 24 · 2023: 48 · 2022: 48 · 2021: 68 · 2020: 63 · 2019: 74 · 2018: 84 · 2017: 67 · 2016: 78 · 2015: 95 · 2014: 75 · 2013: 98 · 2012: 104
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1, hepatic gluconeogenesis, transcriptional coactivator, fasting, insulin resistance, diabetes mellitus, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, glucocorticoid receptor, HNF4α, cyclic AMP, ob/ob mice, streptozotocin-induced diabetes
- MeSH terms
- Cyclic AMP, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Experimental, DNA-Binding Proteins, Fasting, Gluconeogenesis, Hormones, Insulin, Liver, Male, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Phosphoproteins, Receptors, Glucocorticoid, Receptor, Insulin, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, 3T3 Cells, Rats, Wistar, Mice, Knockout, Response Elements, Amino Acid Motifs, Mice, Rats, Hepatocyte Nuclear Factor 4, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.